Cargando…
Correction: Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D(3) receptor agonists
Correction for 'Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D(3) receptor agonists' by Yongkai Cao et al., Med. Chem. Commun., 2018, DOI: 10.1039/c8md00237a.
Autores principales: | Cao, Yongkai, Sun, Ningning, Zhang, Jiumei, Liu, Zhiguo, Tang, Yi-zhe, Wu, Zhengzhi, Kim, Kyeong-Man, Cheon, Seung Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148686/ https://www.ncbi.nlm.nih.gov/pubmed/30289124 http://dx.doi.org/10.1039/c8md90042f |
Ejemplares similares
-
Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor
por: Adhikari, Pramisha, et al.
Publicado: (2021) -
Design and Synthesis of Arylpiperazine Serotonergic/Dopaminergic Ligands with Neuroprotective Properties
por: Mastromarino, Margherita, et al.
Publicado: (2022) -
Design, synthesis, and biological evaluation of N-arylpiperazine derivatives as interferon inducers
por: Chu, Yeonjeong, et al.
Publicado: (2020) -
Bitopic ligands: all-in-one orthosteric and allosteric
por: Kamal, Maud, et al.
Publicado: (2009) -
Design, Synthesis and Biological Activity Evaluation of Arylpiperazine Derivatives for the Treatment of Neuropathic Pain
por: Chen, Yin, et al.
Publicado: (2011)